Blood Coagulation Testing Market Insights Analysis 2020-2027

 Blood coagulation testing is the procedure to diagnose several hemostatic diseases, which is identified by the patients’ inability to coagulate the blood owing to lack of blood clotting proteins. Blood coagulation testing is used for the diagnosis of bleeding disorders, thrombophilia, and hemophilia. The rapidly growing geriatric population is one of the major drives of the market since they are more susceptible to such diseases. The prevalence of hemostatic diseases has been increasing across the globe from the last few years. Increasing healthcare expenditure has provided a push to the growth of the market. However, the high cost of the products and lack of awareness may restrain the market growth.

Increasing prevalence of liver diseases, increasing investment in biotechnology and pharmaceutical industries for research & development, and availability of funds are expected to drive the growth of the market. Moreover, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/970 

The global blood coagulation testing market is projected to reach USD ~7.5 billion by 2023 at a CAGR of 6.5%.

Regional Analysis

The Americas dominate the global blood coagulation testing market owing to the presence of a huge patient population with liver cancer, high health care spending, and increasing government support for research & development.  

Europe holds the second largest share of the global blood coagulation testing market as result of increasing focus of various government agencies on the treatment of rare diseases such as thrombophilia and hemophilia. Moreover, the growing public awareness about the cons of this disease is likely to boost the European market growth.

The Asia Pacific is the fastest growing blood coagulation testing market across the globe, owing to rapidly developing the economy, increasing healthcare awareness, and the government’s support to biotechnology and pharmaceutical industries projected to drive the market in China and India over the forecasted period.

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global blood coagulation market is segmented on the basis of product, application, test type, and end user. On the basis of the product, the market is segmented into clinical laboratory, automated testing, and semi-automated testing. On the basis of the application, the market is segmented into congenital bleeding disorders, acquired bleeding disorders, Von Willebrand disease, and hemophilia. On the basis of the test type, the market is segmented into various testing kits and others. Furthermore, the testing kits are segmented into prothrombin time (PT), activated clotting time, D dimer, and fibrinogen (FIB). On the basis of the end user, the market is segmented into academic institutions, hospitals, and diagnostic laboratories.

Key Players

Some of the major players in the global blood coagulation market are F. Hoffmann-La Roche Ltd. (Europe), Alere Inc. (U.S.), Siemens Healthcare Private Limited (Europe), Accriva Diagnostics (U.S.A.), CoaguSense, Inc. (U.S.), HomoSonics LLC. (U.S.), iLine Microsystems. (Europe), Instrumentation Laboratory (U.S.), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.), and Bio/Data Corporation (U.S.)

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/blood-coagulation-testing-market-970 

 

Test Strip Market Growth Insight Analysis 2020-2027

 Test strip is a type of diagnostic devices which is the most important tools in Point of Care (POC) diagnostics. These test strip helps to achieve rapid diagnosis of various critical diseases such as urinary tract infection (UTI), liver disease, kidney diseases, diabetes test, ophthalmic disease and others with precsion. Test strips are widely used for monitoring the blood glucose level in the diabetic patients. As per world Health Organization (WHO), it was estimated that in 2016, 420 million adult population is suffering from diabetes all over the world will and the number is expected to reach 625 million till 2040.

The global test strip market is growing with the dynamic pace. The global test strip market is expecting a sound growth at a CAGR of 12.8% during the forecasted period. Increasing prevalence of diabetes, and other urinary tract diseases has supported the growth of this market. According to a recent study report published by the Market Research Future, The global test strip market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2021, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2021).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/672 

The market is expected grow with the same trends during the forecast period. The major drivers supporting the growth of the market will be presence of huge diabetic patient population in Asia Pacific region like India and China. According to WHO (2014), 60% of the world’s total diabetic population lives in Asia region. Moreover, the global test strip market is driven by rising geriatric population, and rapid development in the test strips has driven the growth of the market. Moreover, changing lifestyle, and government initiatives for encouragement for the research & development has fuelled the market growth. On the other hand, availability of alternative methods for diagnosis like saliva collection devices has restrained the growth of global test strip market.

Global Test Strip Market - Competitive Analysis

The test strips are based on various technologies such as electrochemical and photometric. Majority of the test strips are based on electrochemical technology. The photometric technology market is expected to witness the highest growth. Roche Diagnostics, Lifescan, Inc., Abbott Laboratories, and Bayer are the leading players in the test strip market, by volume. These players possess state of art manufacturing facilities and strong sales and distribution network which have helped them to gain leadership position in the market. The other prominent players include Arkray Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Chiltern Medicare Ltd, Henry Schein, Lifeassay Diagnostics (Pty), Siemens Healthcare, Taidoc Technology Corporation, and Teco Diagnostics among others are some of the small players that accounts a reasonable amount of share in the test strip market.  

The global test strip market is highly fragmented with the presence of many local players and international players. As a result, local players are focus on cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through FDA approvals, collaborations to expand their overall market share. For instance, Abbot a leading player in the test strip market has received US Food and Drug Administration (FDA) clearance for its new product FreeStyle Lite blood glucose test strips that minimizes the interference during blood glucose testing, hence is fabricated for a better testing experience. This will help Abbott to create an impact on the patient pool and will help to increase its sales by volume.

Hoffmann-La Roche Ltd, Swiss multinational healthcare company focuses on the development and distribution of test strips. For this, in June 2017, Roche has acquired mySugr to form a leading open platform for digital diabetes management. Hence, the growing mergers and acquisitions, new product launches in the field of test strip has upsurged the growth of the market.

Hoffmann-La Roche Ltd (Switzerland), Siemens Ltd. (Germany), Abbott (US), B. Braun (Germany), LifeScan, Inc. (US), Chiltern MediCare Ltd. (US), Henry Schein, Inc. (US), Lifeassay Diagnostics (South Africa), Siemens Healthcare Private Limited (Germany), ARKRAY Inc. (US), Ascensia Diabetes Care Holdings AG. (Switzerland), TaiDoc Technology Corporation (Taiwan), Teco Diagnostics (US) are some of the prominent players at the forefront of competition in the Global Test Strip Market and are profiled in MRFR Analysis.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/test-strip-market-672 

 

COVID-19 Sample Collection Kits Market – Insights on Upcoming Trends 2027

 According to MRFR analysis, the Global COVID-19 Sample Collection Kits Market is expected to register a CAGR of 5.20% during the forecast period of 2020 to 2027 and reach USD 4168.35 Million by 2027

Sample collection usually takes place in a doctor’s room or in a testing laboratory collection center where there are trained specimen collectors who perform the testing services.

The growth of the global COVID-19 sample collection kits market can be contributed for the high demand of sample collection kits, due to the outbreak of COVID-19 globally, and approval of new and advanced detection tests by regulatory authorities.

Furthermore, a rise in the detection of antibodies, an increase in government funding, and a large volume of products & usage rate of swabs are also expected to boost the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9769 

However, a shortage of test-related supplies such as reverse transcription-polymerase chain reaction instruments, swabs, and virus control samples to control COVID-19, and lack of laboratory-based reagents are expected to restrain the growth of the global COVID-19 sample collection kits market.

Several market players such as Medline Industries, Inc., COPAN Diagnostics, and Becton, Dickinson, and Company, among others, currently dominate the global COVID-19 sample collection kits market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the outbreak of COVID-19 in the region. The COVID-19 sample collection kits market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European COVID-19 sample collection kits market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The COVID- 19 sample collection kits market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest-growing region. The COVID -19 sample collection kits market in the Middle East & Africa has been divided into the Middle East and Africa.

The global COVID-19 sample collection kits market has been segmented based on the product type, application, and end user.

On the basis of product type, the market has been segmented into swabs, viral transport media, blood collection kits, and others. The swabs segment is anticipated to be the fastest-growing segment. The swab segment is further divided into nasopharyngeal swabs and oropharyngeal swabs. The Centers for Disease Control and Prevention (CDC) has recommended collecting only nasopharyngeal swabs for testing the sample. The viral transport media is the largest growing segment.

Based on application, the market has been segmented into diagnostic, and research. The diagnostic segment is expected to be the fastest-growing, while the research segment is the largest growing segment.

The market based on end user has been segmented into hospitals & clinics, diagnostics centers, and others. The diagnostic center is anticipated to be the fastest-growing segment. The largest growing segment is hospitals & clinics.

Key Players

Some of the key players in the global COVID-19 sample collection kits market are Thermo Fisher Scientific, Inc. (US), Hardy Diagnostics (US), BNTX Inc. (Germany), Formlabs (US), Medline Industries, Inc. (US), HiMedia Laboratories (India), VIRCELL S.L. (Spain), Puritan Medical Products (US), COPAN Diagnostics (California), Becton, Dickinson, and Company (US), Laboratory Corporation of America Holdings (US), Lucence Diagnostics Pte Ltd. (California)

Segmentation

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/covid-19-sample-collection-kits-market-9769 

 

Global Life Science Analytics Market size and forecast, 2020-2027

 According to MRFR analysis, Life Science Analytics Market is expected to register a CAGR of 11.91% during the forecast period of 2019 to 2025 and was valued at USD 19,165.22 Million in 2018.

Life science analytics is a tool that helps in clinical trials standardization and optimization of the drug discovery process.

The growth of the global life science analytics market can be contributed to growing pressure to curb the healthcare expenditure, need for improved data standardization, and increasing prevalence of chronic diseases. Furthermore, the growing adoption of analytics solutions in clinical trials, increasing adoption of analytics tools for sales & marketing applications, the need for improved patient outcomes, and rising adoption of big data in the life science industry are also expected to fuel the market growth during the forecast period. However, high implementation costs and lack of skilled professionals have expected to restrain the growth of the global life science analytics market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8570 

Several market players such as Allscripts Healthcare, LLC, Cerner Corporation and McKesson Corporation currently dominate the global life science analytics market. The key players are involved in product launches and acquisitions to strengthen their market positions. For instance, in January 2018, Allscripts acquired Practice Fusion for USD 100 million. This acquisition further advance Allscripts’ strategy to offer comprehensive, high performing health information technologies and solutions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2018, owing to the presence of major market players in the region. The life science analytics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European life science analytics market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The life science analytics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rapidly developing life sciences industry, the market in Asia-Pacific is expected to be the fastest-growing. The life science analytics market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Life Science Analytics Market has been segmented based on the type of analytics, application, component, deployment model, and end-user.

Based on the type of analytics, the global life science analytics market has been segmented into predictive analytics, descriptive analytics, and prescriptive analytics. The descriptive analytics segment held the largest market share in 2018 owing to its high preferability by the life science companies, as these solutions help in understanding the past trends.

The global life science analytics market, based on application, has been segmented into research & development, pharmacovigilance, regulatory compliance, sales & marketing, and supply chain optimization. The research & development segment is further sub-segmented into clinical trials and preclinical trials. The research & development segment held the largest market share in 2018 owing to the rising usage in R&D activities for the development of innovative life science products.

The global life science analytics market has been segmented based on component, as software, services, and hardware. The software segment is held the largest market share in 2018 owing to the rising adoption of analytics software in the life science industry.

The global life science analytics market has been segmented, on the basis of deployment model, into on-premise and cloud-based. The on-premise model held the larger market share in 2018 owing to its user-friendly approach.

The market based on end-user has been segmented into hospitals & clinics, pharmaceutical, biotechnology & medical device companies, and others. Hospitals & clinics segment held the largest market share in 2018 as it helps to minimize the clinical errors and increases healthcare productivity.

Key Players

Some of the Key Players in the Global Life Science Analytics Market are Allscripts Healthcare, LLC (US), Cerner Corporation (US), CitiusTech Inc. (US), Health Catalyst (US), Inovalon (US), McKesson Corporation (US), Saama Technologies, Inc. (US), Optum, Inc. (US), SCIOInspire, Corp. (US), SAS Institute Inc. (US), IBM (US), Oracle (US), and IQVIA (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/life-science-analytics-market-8570 

 

Impact of Existing and Emerging Global Pharmacy Management System Market Trends And Forecast 2020-2027

 According to MRFR analysis, Pharmacy Management System Market is expected to register a CAGR of 11.55% during the forecast period of 2019 to 2025 and held a value of USD 37,233 Million in 2018.

The pharmacy management system enables pharmacists to deliver well-organized professional as well as personalized care based on the needs and requirements of the patients. Tools such as eligibility checking, price updates, prior authorization, prescription monitoring program reporting, clinical updates with drug images and prescriber updates, imprints, remote backup, and many other activities are involved in the pharmacy management system solutions.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8563 

The growth of the global pharmacy management system market is boosted by various factors such as rising activities in terms of mergers, joint ventures, acquisitions, partnerships, by key players operating in the market, coupled with the increasing number of prescriptions. For instance, in August 2019, GE Healthcare launched a startup collaboration program, Edison[X], which will work with startups in India to develop solutions to aid patient outcomes and pharmacy practices. However, compound features such as vendor lock-in create a dependency for pharmacists, which complexifies the onboarding of another vendor, which can hinder the preference of such solutions by pharmacists. This can hamper the growth of the market during the forecast period.

Several market players currently dominate the global pharmacy management system market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in February 2019, SRS Pharmacy Systems partnered with STRAND Clinical Technologies to innovate clinic building services, which aims to help pharmacies to launch clinic services within their community.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada. The pharmacy management system market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European pharmacy management system market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The pharmacy management system market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pharmacy management system market in this region is anticipated to be the fastest-growing during the assessment period due to the increased adoption rate of pharmacy management software by local pharmacy facilities in the Asian countries. The pharmacy management system market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Pharmacy Management System Market has been segmented based on solution type, component, deployment mode, and end-user.

The market, based on solution type, has been divided into pharmacy inventory management systems, pharmacy data management systems, pharmacy compounding software systems, pharmacy benefits management systems, pharmacy revenue cycle management systems, and others. The pharmacy inventory management system segment is likely to be the largest due to the increased usage of such solution for the proper management of pharmacies. The pharmacy data management system segment is predicted to be the fastest-growing due to the increasing awareness about the advantages of such solutions.

The Global Pharmacy Management System Market has been segmented, based on the component, into software, hardware, and services. The software segment is expected to hold the majority share of the market owing to the increasing number of solution launches. The hardware segment is expected to be the fastest-growing due to the increased use of hardware in the pharmacy management activities.

The Global Pharmacy Management System Market, based on the deployment model, has been segmented into cloud/web-based, and on-premise. The cloud/web-based segment holds the maximum share owing to the rise in the launch of cloud-based solutions in recent years. The on-premise segment is anticipated to be the fastest-growing during the assessment period due to the high usage of on-premise solutions.

The end-users of the market are inpatient pharmacies and outpatient pharmacies. The market for inpatient pharmacies has been further divided into acute care settings and long-term care facilities. The market for outpatient pharmacies has been bifurcated into fast-track clinics and hospital retail settings.

Key Players

Some of the Key Players in the Global Pharmacy Management System Market are Allscripts (US), Cerner Corporation (US), Datascan (US), McKesson (US), Epicor Software (US), GlobeMed Group (Lebanon), ScriptPro (US), Clanwilliam Liberty Software (US), LS Retail (Iceland), MedHOK (US), Octal IT Solution LLP (US), Safe care Technology (UAE), Health (Ireland), Mobile MedSoft (US), and Health Business Systems (US).

 Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/pharmacy-management-system-market/toc 

 

Global Patient Handling Equipment Market size and forecast, 2020-2027

 Market Analysis 

The surge in pandemic-induced patient volume is estimated to bolster the patient handling equipment market. The market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. The market is anticipated to gain USD 15,430.18 Million at a CAGR of 8.3% by 2027.

The development of robust products to aid in different setups is estimated to stimulate the patient handling equipment market in the approaching period. The rise in the number of rehabilitation centers and elderly care settings is predicted to motivate the expansion of the patient handling equipment market stake.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9986 

Segmental Analysis

The segmental scrutiny of the patient handling equipment market is carried out on the basis of type, product, application, end user and region. The type segment of the patient handling equipment market consists of fall prevention, critical care, wound care and bariatric care. The end-user segment of the patient handling equipment market consists of hospitals and home care settings. The region segment of the patient handling equipment market consists of the Americas, Middle East & Africa, Europe, and the Asia Pacific. The product segment of the patient handling equipment market consists of ambulatory aids, medical beds, wheelchairs & mobility scooters, patient transfer devices, bathroom & toilet assist equipment, stretchers & transport chairs. The application segment of the patient handling equipment market consists of long-term care, mobility assistance, acute & critical care.

Regional Overview

The regional review of the patient handling equipment market consists of the Americas, Middle East & Africa, Europe, and the Asia Pacific. The Americas patient handling equipment market is the largest regional market. The swelling occurrence rate of obesity is anticipated to increase the development of the market throughout the forecast period. The European regional market held the second principal position in the market due to high research and development financing. The Asia Pacific region is the quickest growing regional market for patient handling equipment due to the mounting life expectancy rate. Also, mounting healthcare spending is driving the growth of the patient handling equipment market. Such intensifying expenditure supported by the life expectancy rate is anticipated to boost the call for patient handling devices in the upcoming years. The Middle East & African region is expected to display steady growth due to the high rate of overweightedness. Though, inadequate healthcare infrastructure in the region is foreseeable to hinder the patient handling equipment market growth in the forecast period.

Competitive Analysis

The investment towards cutting-edge technology is anticipated to take a sharp surge with amplified funding accessibility. The market is projected to witness a period of turbulence with the impact of the pandemic on the workforce and the economy as a whole. The collaborative efforts of the market contenders are expected to broaden the horizons for development in the foreseeable future. The measures being undertaken to ensure seamless functioning of the market is estimated to lay off in the long run. The contenders in the market are likely to see aggressive competition in the coming years. The reimagined market structure is predicted to rely on a combination of robust online selling capabilities and a capable supply chain. The formation of strong trade relations among several regions is forecasted to have a beneficial effect on growth. The focus on the client's needs is estimated to be more important than before as changes in living standards can have a notable bearing on the popularity of certain market trends.

The well-known companies in the patient handling equipment market are Prism Medical UK (UK), Arjo (Sweden), Ossenberg GmbH (Germany), Hill-Rom Services Inc. (US), Invacare Corporation (US), GF Health Products, Inc. (US), Etac AB (Sweden), Joerns Healthcare LLC (US), Medline Industries, Inc. (US), McAuley Medical, Inc. (US), Handicare (Sweden), EZ Way, Inc. (US), LINET (Czech Republic), Savaria (Canada), Malvestio Spa (Italy), Stryker (US) and Stiegelmeyer GmbH & Co. KG (Germany).

Industry Updates:

Mar 2021 Direct Healthcare Group has finished the purchase of the Dutch patient handling solutions producer United Care BV. The Groningen-based outfit claims more than 25 years of knowledge in the growth and production of patient handling solutions that bring safe, reliable and organic transfers for patients and competencies and lessening of injuries for caregivers. The purchase of United Care enhances the Direct Healthcare Group's safe moving and handling collection, with a joint focus on promoting movement and individuality to progress quality of living for the patient.

Nov 2020 Sunderland's Lynch Healthcare Group has been purchased by Direct Healthcare Group (DHG), the European producer of pressure care, patient handling and expert seating solutions. Lynch creates a range of hoisting equipment, patient slings, and shower chairs, counting the David Lynch Tailored variety. Through the purchase, DHG further widens its patient-handling sling solutions and bathroom safety results because of the Austin Shower Cradle. The transfer also raises DHG's ability to deliver customer services to its UK clientele.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/patient-handling-equipment-market-9986 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Payment Fraud Detection Market to Witness Widespread Expansion During 2020-2027

 Market Analysis 

Health fraud is an intentional deception or misrepresentation of fact that can result in unauthorized benefit or payment.

The growth of the medical payment fraud detection market is due to the unpredicted surge of healthcare scams and fraud during the COVID 19 outbreak, a rising number of patients opting for health insurance, and rising healthcare expenditure.

Furthermore, a large number of false or fake activities, increasing pressure of fraud and abuse on healthcare spending, and growing pressure to increase operational efficiency and reduce healthcare spending, are also expected to fuel the market during the forecast period.

However, the lack of skilled professionals and unwillingness to adopt the fraud analytics system in developing countries are expected to restrain the growth of the medical payment fraud detection market.

Medical Payment Fraud Detection Market is expected to hold a value of USD 5786.44 Million by 2027 and medical payment fraud detection market is expected to register a growth of 25.2% from 2020 to 2027.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9778 

Several market players such as SAS Institute, LexisNexis Risk Solutions, and Optuminsight, among others currently dominate the global medical payment fraud detection market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the increasing number of patients opting for health insurances. For Instance, according to the Centers for Disease Detection and Prevention, in 2018 report, 25.5% people under age of 65 opted for public health insurance in the United States. The medical payment fraud detection market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European medical payment fraud detection market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, Italy, Spain, the UK and the rest of Western Europe. The medical payment fraud detection market in Asia-Pacific has been segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. Due to large number of fraudulent activities, the market in Asia-Pacific is expected to be the fastest-growing. The medical payment fraud detection market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

Global Medical Payment Fraud Detection Market has been segmented based on the Type, Component, Delivery Model, Source of Services, and End User.

Based on Type, the global medical payment fraud detection market has been segmented into descriptive analytics, predictive analytics, and prescriptive analytics. Descriptive analytics forms the base for the effective application of predictive and prescriptive analytics.

On the basis of components, the market has been segmented into services and software. Software fraud detection is expected to hold a major market share.

Based on the delivery model, the market has been segmented into on-premise and cloud-based. The cloud-based fraud detection market is expected to gain traction during the forecast period.

On the basis of the source of service, the market has been segmented into in-house and outsourced.

The market based on end-user has been segmented into private insurance payers, public/ government agencies, and third-party service providers.

Key Players

Some of the key players in the global medical payment fraud detection market are LexisNexis Risk Solutions (US), International Business Machines Corporation (US), Optuminsight (US), OSP Labs (India), DXC Technology Company (US), UnitedHealth Group (US), SAS Institute (US), Fair Issac Corporation (US), EXL Service Holdings, Inc. (US), CGI GROUP (Canada).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-payment-fraud-detection-market-9778 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com